Impact of sarilumab on mechanical ventilation in patients with COVID-19. Response to: 'Correspondence on: 'Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation-an open-label cohort study' by Della-Torre et al ' by Cheng and Zhang / Della-Torre, E.; Landoni, G.; Zangrillo, A.; Dagna, L.. - In: ANNALS OF THE RHEUMATIC DISEASES. - ISSN 0003-4967. - 81:10(2022), pp. 197-198. [10.1136/annrheumdis-2020-218724]
Impact of sarilumab on mechanical ventilation in patients with COVID-19. Response to: 'Correspondence on: 'Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation-an open-label cohort study' by Della-Torre et al ' by Cheng and Zhang
Landoni G.Secondo
;Zangrillo A.Penultimo
;Dagna L.Ultimo
2022-01-01
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Impact of sarilumab on mechanical ventilation in patients with COVID-19.pdf
accesso aperto
Tipologia:
PDF editoriale (versione pubblicata dall'editore)
Licenza:
Creative commons
Dimensione
210.19 kB
Formato
Adobe PDF
|
210.19 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
